TransMedics Group Inc (TMDX)

Cash ratio

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Cash and cash equivalents	US$ in thousands	336,650	330,094	362,751	350,217	394,812	427,110	582,210	195,375	201,182	204,462	30,386	17,897	25,580	22,495	25,314	26,727	24,581	21,397	51,152	24,738
Short-term investments	US$ in thousands	—	—	—	—	—	—	—	—	0	0	27,697	54,104	66,872	80,360	86,935	91,386	101,061	111,317	88,223	47,816
Total current liabilities	US$ in thousands	59,913	60,048	54,329	50,223	54,934	49,101	32,017	28,635	23,661	20,689	22,741	20,256	23,238	15,923	15,079	11,757	11,879	13,624	13,818	15,039
Cash ratio		5.62	5.50	6.68	6.97	7.19	8.70	18.18	6.82	8.50	9.88	2.55	3.55	3.98	6.46	7.44	10.05	10.58	9.74	10.09	4.82

December 31, 2024 calculation

Cash ratio = (Cash and cash equivalents + Short-term investments) ÷ Total current liabilities
= ($336,650K + $—K) ÷ $59,913K
= 5.62

The cash ratio of TransMedics Group Inc has fluctuated over the reporting periods provided. The cash ratio measures the company's ability to cover its short-term liabilities using its cash and cash equivalents.

From March 31, 2020, to June 30, 2022, the cash ratio generally decreased from 4.82 to 2.55, indicating a potential decrease in the company's ability to cover its short-term liabilities with its available cash during this period.

However, from September 30, 2022, to June 30, 2024, the cash ratio showed improvements, rising from 9.88 to 6.68. This increase suggests that the company had better liquidity and was in a stronger position to cover its short-term obligations with its cash reserves during these periods.

The cash ratio peaked at 18.18 on June 30, 2023, which may indicate a significant increase in liquid assets compared to current liabilities. This could be a positive sign of strong liquidity management during that specific period.

Overall, fluctuations in the cash ratio of TransMedics Group Inc over the reporting periods highlight variations in the company's cash position and its ability to meet short-term obligations with available cash and cash equivalents.